117 related articles for article (PubMed ID: 11724643)
1. Lymphocyte protein synthesis is increased with the progression of HIV-associated disease to AIDS.
Caso G; Garlick PJ; Gelato MC; McNurlan MA
Clin Sci (Lond); 2001 Dec; 101(6):583-9. PubMed ID: 11724643
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
[TBL] [Abstract][Full Text] [Related]
3. Interferon and tumor necrosis factor responses of HIV+ patients as markers for monitoring of the AIDS progression.
Piasecki E; Ledwoń TK; Inglot AD; Knysz B; Simon K; Inglot M; Gładysz A
Arch Immunol Ther Exp (Warsz); 1994; 42(5-6):439-45. PubMed ID: 8572904
[TBL] [Abstract][Full Text] [Related]
4. Thyroid hormone: a "prime suspect" in human immunodeficiency virus (HIV/AIDS) patients?
Amadi K; Sabo AM; Ogunkeye OO; Oluwole FS
Niger J Physiol Sci; 2008; 23(1-2):61-6. PubMed ID: 19434216
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein is a marker for human immunodeficiency virus disease progression.
Lau B; Sharrett AR; Kingsley LA; Post W; Palella FJ; Visscher B; Gange SJ
Arch Intern Med; 2006 Jan; 166(1):64-70. PubMed ID: 16401812
[TBL] [Abstract][Full Text] [Related]
6. Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection.
Look MP; Rockstroh JK; Rao GS; Kreuzer KA; Spengler U; Sauerbruch T
Biol Trace Elem Res; 1997 Jan; 56(1):31-41. PubMed ID: 9152510
[TBL] [Abstract][Full Text] [Related]
7. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
8. Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection.
Godfried MH; van der Poll T; Jansen J; Romijin JA; Schattenkerk JK; Endert E; van Deventer SJ; Sauerwein HP
AIDS; 1993 Jan; 7(1):33-6. PubMed ID: 8382926
[TBL] [Abstract][Full Text] [Related]
9. Cytokine expression during syphilis infection in HIV-1-infected individuals.
Knudsen A; Benfield T; Kofoed K
Sex Transm Dis; 2009 May; 36(5):300-4. PubMed ID: 19265730
[TBL] [Abstract][Full Text] [Related]
10. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.
Martinez V; Diemert MC; Braibant M; Potard V; Charuel JL; Barin F; Costagliola D; Caumes E; Clauvel JP; Autran B; Musset L;
Clin Infect Dis; 2009 Jan; 48(1):123-32. PubMed ID: 19035778
[TBL] [Abstract][Full Text] [Related]
11. Weight gain and increased concentrations of receptor proteins for tumor necrosis factor after patients with symptomatic HIV infection received fortified nutrition support.
Süttmann U; Ockenga J; Schneider H; Selberg O; Schlesinger A; Gallati H; Wolfram G; Deicher H; Müller MJ
J Am Diet Assoc; 1996 Jun; 96(6):565-9. PubMed ID: 8655902
[TBL] [Abstract][Full Text] [Related]
12. [Role of tumor necrosis factor-a, nitric oxide and markers of clinical progression in the nutritional status of children with vertically-acquired hiv-1infection].
Resino S; Bellón J; González Nicolás J; Navarro M; Muñoz Fernández M
An Esp Pediatr; 2001 May; 54(5):450-7. PubMed ID: 11333474
[TBL] [Abstract][Full Text] [Related]
13. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
[TBL] [Abstract][Full Text] [Related]
14. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.
Mildvan D; Spritzler J; Grossberg SE; Fahey JL; Johnston DM; Schock BR; Kagan J
Clin Infect Dis; 2005 Mar; 40(6):853-8. PubMed ID: 15736019
[TBL] [Abstract][Full Text] [Related]
15. Plasma selenium concentration and glutathione peroxidase activity in HIV-1/AIDS infected patients: a correlation with the disease progression.
Ogunro PS; Ogungbamigbe TO; Elemie PO; Egbewale BE; Adewole TA
Niger Postgrad Med J; 2006 Mar; 13(1):1-5. PubMed ID: 16633369
[TBL] [Abstract][Full Text] [Related]
16. Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy.
Akerele T; Galatowicz G; Bunce C; Calder V; Lynn WA; Lightman S
Clin Immunol; 2006 Nov; 121(2):191-7. PubMed ID: 16987710
[TBL] [Abstract][Full Text] [Related]
17. Serum lipid concentration with reference to the clinical and immunological status of HIV infected men.
Christeff N; Lortholary O; Casassus P; Thobie N; Dalle MT; Veyssier P; Guillevin L; Nunez EA
Ann Med Interne (Paris); 1995; 146(7):490-5. PubMed ID: 8787290
[TBL] [Abstract][Full Text] [Related]
18. Cytokine profile in human immunodeficiency virus positive patients with and without tuberculosis.
Agarwal SK; Singh A; Anuradha S; Singh NP; Sokhi J; Baveja UK
J Assoc Physicians India; 2001 Aug; 49():799-802. PubMed ID: 11837467
[TBL] [Abstract][Full Text] [Related]
19. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
20. Different plasma levels of interleukins and chemokines: comparison between children and adults with AIDS in China.
Jin CZ; Zhao Y; Zhang FJ; Yao HP; Wu LJ; Zhao HX; Wei HS; Wu NP
Chin Med J (Engl); 2009 Mar; 122(5):530-5. PubMed ID: 19323903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
